Solid Biosciences (NASDAQ:SLDB) Now Covered by Analysts at Citigroup

Stock analysts at Citigroup initiated coverage on shares of Solid Biosciences (NASDAQ:SLDB – Get Free Report) in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $14.00 price target on the stock. Citigroup…

Read Full Article →